Cargando…

Assessing the quality of information provided on websites selling Kratom (Mitragyna speciosa) to consumers in Canada

BACKGROUND: Amid a Canadian opioid crisis, many have turned to natural health products, such as kratom (Mitragyna speciosa), to manage their opioid withdrawal. Kratom has also been reported to relieve anxiety, improve stamina, and heighten physical performance. Given that kratom is not authorized fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Ng, Jeremy Y., Ans, Muhammad, Marwaha, Amn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7977165/
https://www.ncbi.nlm.nih.gov/pubmed/33741009
http://dx.doi.org/10.1186/s13011-021-00361-2
_version_ 1783667085345292288
author Ng, Jeremy Y.
Ans, Muhammad
Marwaha, Amn
author_facet Ng, Jeremy Y.
Ans, Muhammad
Marwaha, Amn
author_sort Ng, Jeremy Y.
collection PubMed
description BACKGROUND: Amid a Canadian opioid crisis, many have turned to natural health products, such as kratom (Mitragyna speciosa), to manage their opioid withdrawal. Kratom has also been reported to relieve anxiety, improve stamina, and heighten physical performance. Given that kratom is not authorized for sale by Health Canada, many have turned to online retailers to purchase kratom due to its easy accessibility online. This study investigated the quality of consumer health information provided on the websites of online vendors selling kratom to consumers in Canada. METHODS: Following searches on Google.ca using search terms designed to simulate the information-seeking behaviour of a typical patient-user online, eligible websites were assessed using the 16-question DISCERN instrument, a tool designed to assess the quality of consumer health information. Searches were conducted on March 27, 2020 and only websites presenting information in English were included. RESULTS: A total of 200 webpages were identified; after screening based on eligibility criteria and combining different webpages that belonged to the same website, 51 websites were found to be eligible. The mean summed DISCERN score across all 51 websites was 36.95 (SD = 2.44) out of 75, which reflects poor quality consumer health information across the subset of websites. The overall quality of websites was poor, as 78% (n = 40) of vendors received a score of 2 or less out of 5. CONCLUSIONS: Individuals who seek information about kratom online are frequently exposed to poor quality consumer health information. Those looking to purchase kratom online are not provided with the critical information necessary to make an informed decision regarding its use, such as the complete details about the risks and side effects or a description of how kratom affects the body. Given the growing interest in kratom, knowledge of the quality of information available can lead to improved dialogue between healthcare providers and patients.
format Online
Article
Text
id pubmed-7977165
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-79771652021-03-22 Assessing the quality of information provided on websites selling Kratom (Mitragyna speciosa) to consumers in Canada Ng, Jeremy Y. Ans, Muhammad Marwaha, Amn Subst Abuse Treat Prev Policy Research BACKGROUND: Amid a Canadian opioid crisis, many have turned to natural health products, such as kratom (Mitragyna speciosa), to manage their opioid withdrawal. Kratom has also been reported to relieve anxiety, improve stamina, and heighten physical performance. Given that kratom is not authorized for sale by Health Canada, many have turned to online retailers to purchase kratom due to its easy accessibility online. This study investigated the quality of consumer health information provided on the websites of online vendors selling kratom to consumers in Canada. METHODS: Following searches on Google.ca using search terms designed to simulate the information-seeking behaviour of a typical patient-user online, eligible websites were assessed using the 16-question DISCERN instrument, a tool designed to assess the quality of consumer health information. Searches were conducted on March 27, 2020 and only websites presenting information in English were included. RESULTS: A total of 200 webpages were identified; after screening based on eligibility criteria and combining different webpages that belonged to the same website, 51 websites were found to be eligible. The mean summed DISCERN score across all 51 websites was 36.95 (SD = 2.44) out of 75, which reflects poor quality consumer health information across the subset of websites. The overall quality of websites was poor, as 78% (n = 40) of vendors received a score of 2 or less out of 5. CONCLUSIONS: Individuals who seek information about kratom online are frequently exposed to poor quality consumer health information. Those looking to purchase kratom online are not provided with the critical information necessary to make an informed decision regarding its use, such as the complete details about the risks and side effects or a description of how kratom affects the body. Given the growing interest in kratom, knowledge of the quality of information available can lead to improved dialogue between healthcare providers and patients. BioMed Central 2021-03-19 /pmc/articles/PMC7977165/ /pubmed/33741009 http://dx.doi.org/10.1186/s13011-021-00361-2 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Ng, Jeremy Y.
Ans, Muhammad
Marwaha, Amn
Assessing the quality of information provided on websites selling Kratom (Mitragyna speciosa) to consumers in Canada
title Assessing the quality of information provided on websites selling Kratom (Mitragyna speciosa) to consumers in Canada
title_full Assessing the quality of information provided on websites selling Kratom (Mitragyna speciosa) to consumers in Canada
title_fullStr Assessing the quality of information provided on websites selling Kratom (Mitragyna speciosa) to consumers in Canada
title_full_unstemmed Assessing the quality of information provided on websites selling Kratom (Mitragyna speciosa) to consumers in Canada
title_short Assessing the quality of information provided on websites selling Kratom (Mitragyna speciosa) to consumers in Canada
title_sort assessing the quality of information provided on websites selling kratom (mitragyna speciosa) to consumers in canada
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7977165/
https://www.ncbi.nlm.nih.gov/pubmed/33741009
http://dx.doi.org/10.1186/s13011-021-00361-2
work_keys_str_mv AT ngjeremyy assessingthequalityofinformationprovidedonwebsitessellingkratommitragynaspeciosatoconsumersincanada
AT ansmuhammad assessingthequalityofinformationprovidedonwebsitessellingkratommitragynaspeciosatoconsumersincanada
AT marwahaamn assessingthequalityofinformationprovidedonwebsitessellingkratommitragynaspeciosatoconsumersincanada